If this is your first visit, be sure to
check out the FAQ by clicking the
link above. You may have to register
before you can post: click the register link above to proceed. To start viewing messages,
select the forum that you want to visit from the selection below.
I haven't looked at the numbers recently, but these biotechs with one main product get crushed if the FDA rejects them. Plus they were slammed by some biotech bloggers recently... all I would care about on this possible bounce would be buying at 3.39 and selling at like 3.59 later today for a 5-6% bounce.
I haven't looked at the numbers recently, but these biotechs with one main product get crushed if the FDA rejects them. Plus they were slammed by some biotech bloggers recently... all I would care about on this possible bounce would be buying at 3.39 and selling at like 3.59 later today for a 5-6% bounce.
I think OXGN already had it's runup a few weeks ago because of a presentation at the cancer conference. It seems to be going back down to the low $2.
On a positive note, I sold 70 of my 160 msft contracts this morning for $4.10, booking a $0.35 gain ($2450). Small change for gambler, but decent for little ole me. Still have the other 90 contracts hoping for another few pennies.
Nicely done, profit is profit. And the amount doesn't matter, it is the percentage gain.
On a side note, in this market, bios are getting very skittish... moves happen alot faster and you have to take profits sooner.... Look at the biorundowns (after FDA approval) such as ACUR, FCSC, and the damage to stocks like PTIE/DRRX. Favors a reversion to mean strategy, imo.
Watching PRAN for bounce some day, 1.75 now. Also SVNT at 6.69.
As far as OXGN goes, the runup into ASCO was the catalyst back then, but at some point, the pullback is too much and a bounce is overdue. It is close to that point now. No position.
Hmm.. not liking OXGN here at 2.46, would take a small loss of 1% and sell. We'll see, it probably goes to like 3.25 in a week, hehe
I think OXGN already had it's runup a few weeks ago because of a presentation at the cancer conference. It seems to be going back down to the low $2.
On a positive note, I sold 70 of my 160 msft contracts this morning for $4.10, booking a $0.35 gain ($2450). Small change for gambler, but decent for little ole me. Still have the other 90 contracts hoping for another few pennies.
Edit: Just to clarify for the non-option trading majority of SA,
Each 'Call' is a contract for 100 shares. So if calls are trading at 3.75, each contract costs 375$... So if someone traded 160 contracts, that means he put on a position of 375$*160 = 60,000$
Not sure how big your trading account is, but a profit of 60,000$ in half a year ain't too shabby
Yeah, I have to use options with large caps like microsoft to get them to return anything decent with the relatively small moves they make. With biotechs you can get 100% moves by just holding the stock. At least LEAPS are someone safer since they provide about 6x leverage and not too much time value spent on the ITM ones.
Hopefully this play will go similar to last year. Actually, if you look at the 5 year chart, Microsoft spikes higher in Jan of every year, except for 2009 when it (and every other stock) spiked horribly down. The downspike was super short though, since it was not based on anything other than general market panic.
Leave a comment: